21 CFR 520.540c

§ 520.540c Dexamethasone chewable tablets.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.540c, § 520.540c Dexamethasone chewable tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87121
Permanent ID: ys:prov:87121@1
SHA-256: 8ca6ebee6ce85955eb9167834c7718fe4263be39cbdf12a7919e205117b2c4ee

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each half-scored tablet contains 0.25 milligram of dexamethasone. (b) Sponsor. See No. 051031 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer by free-choice feeding or crumbled over food 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved. (2) Indications for use. As supportive therapy in nonspecific dermatosis and inflammatory conditions. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.